Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-25-000067

Chief Financial Officer sold 1,780 shares at $33.54 ($59,701)

  • Chief Financial Officer acquired 6,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Jones Cecilia · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-06-24 Exercise or conversion : show line 1 in the form 10b5-1 +6,000 31,829 D
2025-06-24 Sale : show line 2 in the form 10b5-1 −1,780 $33.54 $59,701 30,049 D
Open-market sales · 1,780 sh · avg $33.54 · $59,701

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-06-24 Exercise or conversion : show line 3 in the form 10b5-1 Performance share units −6,000 6,000 D
Loading xslF345X05/wk-form4_1750973073.xml…